1. Home
  2. CDNA vs INVX Comparison

CDNA vs INVX Comparison

Compare CDNA & INVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • INVX
  • Stock Information
  • Founded
  • CDNA 1998
  • INVX 2024
  • Country
  • CDNA United States
  • INVX United States
  • Employees
  • CDNA N/A
  • INVX N/A
  • Industry
  • CDNA Medical Specialities
  • INVX
  • Sector
  • CDNA Health Care
  • INVX
  • Exchange
  • CDNA Nasdaq
  • INVX NYSE
  • Market Cap
  • CDNA 1.1B
  • INVX 954.4M
  • IPO Year
  • CDNA 2014
  • INVX N/A
  • Fundamental
  • Price
  • CDNA $18.90
  • INVX $15.16
  • Analyst Decision
  • CDNA Buy
  • INVX Sell
  • Analyst Count
  • CDNA 8
  • INVX 1
  • Target Price
  • CDNA $29.43
  • INVX $16.00
  • AVG Volume (30 Days)
  • CDNA 661.3K
  • INVX 454.4K
  • Earning Date
  • CDNA 04-30-2025
  • INVX 05-11-2025
  • Dividend Yield
  • CDNA N/A
  • INVX N/A
  • EPS Growth
  • CDNA N/A
  • INVX 20.96
  • EPS
  • CDNA 0.93
  • INVX 2.77
  • Revenue
  • CDNA $333,785,000.00
  • INVX $660,803,000.00
  • Revenue This Year
  • CDNA $13.33
  • INVX $56.02
  • Revenue Next Year
  • CDNA $15.07
  • INVX $2.42
  • P/E Ratio
  • CDNA $20.32
  • INVX $5.47
  • Revenue Growth
  • CDNA 19.07
  • INVX 18.95
  • 52 Week Low
  • CDNA $7.42
  • INVX $12.54
  • 52 Week High
  • CDNA $34.84
  • INVX $22.10
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 50.38
  • INVX N/A
  • Support Level
  • CDNA $15.78
  • INVX N/A
  • Resistance Level
  • CDNA $20.13
  • INVX N/A
  • Average True Range (ATR)
  • CDNA 1.37
  • INVX 0.00
  • MACD
  • CDNA 0.24
  • INVX 0.00
  • Stochastic Oscillator
  • CDNA 71.72
  • INVX 0.00

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About INVX INNOVEX INTERNATIONAL INC

Innovex International Inc designs, manufactures, and installs mission-critical drilling & deployment, well construction, completion, production, and fishing & intervention solutions to support upstream onshore and offshore activities worldwide. Its comprehensive portfolio extends throughout the lifecycle of the well; and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer. With locations throughout North America, Latin America, Europe, the Middle East, and Asia, The team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

Share on Social Networks: